Fulvestrant

Sort by

AN04035

  • CAT Number DCTI-C-611
  • CAS Number 2389169-23-5
  • Molecular Formula C33H50F5O7PS
  • Molecular Weight 716.78

Fulvestrant R enantiomer

  • CAT NUMBER DCTI-C-2289
  • CAS NUMBER 1807900-80-6
  • MOLECULAR FORMULA C32H47F5O3S
  • MOLECULAR WEIGHT 606.78

Fulvestrant Related Impurity

  • CAT NUMBER DCTI-C-2568
  • CAS NUMBER NA
  • MOLECULAR FORMULA C38H54F5NO5S
  • MOLECULAR WEIGHT 731.9

Fulvestrant S enantiomer

  • CAT NUMBER DCTI-C-2288
  • CAS NUMBER 1316849-17-8
  • MOLECULAR FORMULA C32H47F5O3S
  • MOLECULAR WEIGHT 606.78

General Information

Fulvestrant Impurities and Fulvestrant

Daicel Pharma specializes in synthesizing impurities for Fulvestrant, an active pharmaceutical ingredient. We offer impurities such as AN04035, Fulvestrant R enantiomer, Fulvestrant Related Impurity, and Fulvestrant S enantiomer, which play a vital role in evaluating the purity and safety of Fulvestrant. Daicel Pharma also provides custom synthesis of Fulvestrant impurities to meet specific client needs and offer worldwide delivery options.

Fulvestrant [CAS: 129453-61-8] is a synthetic estrogen receptor antagonist that treats hormone-receptor-positive metastatic breast cancer. It is for estrogen receptor-positive, locally advanced, or metastatic breast cancer cases.

Fulvestrant: Use and Commercial Availability  

Fulvestrant, sold under Faslodex, has clinical benefits primarily in postmenopausal women with HR-positive and HER2-negative breast cancer. Fulvestrant treats advanced breast cancer, including cases with large tumors, extensive lymph node metastasis, and invasion into surrounding tissues and organs.

Fulvestrant Structure and Mechanism of Action Fulvestrant Structure and Mechanism of Action

The chemical name of Fulvestrant is (7α,17β)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol. Its chemical formula is C32H47F5O3S, and its molecular weight is approximately 606.8 g/mol.

Fulvestrant binds to the estrogen receptors and downregulates the ER protein in human breast cancer cells.

Fulvestrant Impurities and Synthesis

Impurities in Fulvestrant are unintended substances that may be present in the drug product, apart from the desired active ingredient. They can originate from various sources, including raw materials, synthesis processes, or degradation of Fulvestrant over time. Examples of impurities in Fulvestrant can include related compounds, residual solvents, degradation products, or impurities introduced during manufacturing. Effective control and monitoring of impurities in Fulvestrant are essential to ensure the medicine’s quality, safety, and efficacy.

Daicel Pharma, in adherence to cGMP standards, operates an analytical facility where we prepare Fulvestrant impurity standards like AN04035, Fulvestrant R enantiomer, Fulvestrant Related Impurity, and Fulvestrant S enantiomer. We offer a comprehensive Certificate of Analysis (CoA) for these impurities, providing a detailed characterization report. The CoA includes data obtained through techniques, 1H NMR, 13C NMR, IR, MASS, and HPLC purity analysis1,2. Upon request, we give additional data like 13C-DEPT. We can synthesize unknown Fulvestrant impurities or degradation products. Each delivery has a comprehensive characterization report.

References
FAQ's

Frequently Asked Questions

The impurities in Fulvestrant are continuously monitored during its manufacturing process. Quality control measures, including in-process testing and analysis, ensure the ongoing control of impurity levels.

Impurities in Fulvestrant have the potential to cause variability in its therapeutic response. They can interfere with the drug's mechanism of action or alter its pharmacokinetics. Their strict control help minimizes such variability to ensure a consistent therapeutic response.

Yes, regulatory authorities provide specific limits or thresholds for impurity levels in Fulvestrant. These limits are established based on safety considerations and are included in regulatory guidelines. Manufacturers must adhere to these limits to ensure the quality and safety of Fulvestrant.

The recommendation is to store Fulvestrant impurities at a controlled room temperature, within 2-8 °C (Light sensitive). However, Fulvestrant impurities such as AN04035 are stored at -20 °C in a nitrogen atmosphere.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart